Mayewell Capital
Finance · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
469 Rolling Rd, Bryn Mawr, Pennsylvania,...Phone Number
(484) 222-1342Website
www.mayewellcapital.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Mayewell Capital
Mayewell Capital specializes in the commercialization of off-patent brand-name drugs, newly approved innovative drugs, and generic drugs in the Asia-Pacific (APAC) region. They collaborate with pharmaceutical companies to acquire rights for these drugs and engage in equity investments in biotech firms at the Pre-IPO stage. Additionally, they facilitate the establishment of biotech companies in the APAC region to develop drug assets and create value aimed at IPO. Their intended clients include pharmaceutical companies, biotech firms, and investment partners looking for opportunities in the healthcare sector.Explore more
Popular SearchesMayewell Capital LLCMayewellcapitalSIC Code 67,679NAICS Code 52,523Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mayewell Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Mayewell Capital is spiking on competitors!
Check if Mayewell Capital has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Mayewell Capital recently announced quarterly report
Product Launch: Get notified when Mayewell Capital launches new products
Funding: Get notified immidiatlly once Mayewell Capital has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Mayewell Capital had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Mayewell Capital
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Mayewell Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Mayewell Capital
Find 3 more new buyers
Compare Similar Companies to Mayewell Capital
Compare insights from companies similar to Mayewell Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mayewell Capital
<$5M
1-10
Private
-
2016
N/A
Company Profile Activity
Activity Insights
Mayewell Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Mayewell Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Mayewell Capital.
Mayewell Capital Tech Stack
A closer look at the technologies used by Mayewell Capital
Top Finance Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mayewell Capital
Sign Up For FreeTo access detailed company insights
Mayewell Capital specializes in the commercialization of off-patent brand-name drugs, newly approved innovative drugs, and generic drugs in the Asia-Pacific (APAC) region. They collaborate with pharmaceutical companies to acquire rights for these drugs and engage in equity investments in biotech firms at the Pre-IPO stage. Additionally, they facili... Read More
